Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 06 04:00PM ET
11.63
Dollar change
-0.32
Percentage change
-2.68
%
IndexRUT P/E- EPS (ttm)-2.77 Insider Own5.03% Shs Outstand160.09M Perf Week2.02%
Market Cap1.86B Forward P/E- EPS next Y-0.27 Insider Trans-0.94% Shs Float152.03M Perf Month8.59%
Income-294.33M PEG- EPS next Q-0.90 Inst Own52.36% Short Float20.06% Perf Quarter-40.53%
Sales987.67M P/S1.89 EPS this Y81.70% Inst Trans2.80% Short Ratio3.52 Perf Half Y107.31%
Book/sh-2.70 P/B- EPS next Y72.53% ROA-16.80% Short Interest30.50M Perf Year19.40%
Cash/sh6.62 P/C1.76 EPS next 5Y37.90% ROE- 52W Range3.53 - 23.86 Perf YTD142.29%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-51.26% Beta2.05
Dividend TTM- Quick Ratio1.03 Sales past 5Y513.29% Gross Margin66.32% 52W Low229.24% ATR (14)1.05
Dividend Ex-DateDec 13, 2007 Current Ratio1.04 EPS Y/Y TTM62.96% Oper. Margin-28.95% RSI (14)44.54 Volatility10.44% 8.55%
Employees1543 Debt/Eq- Sales Y/Y TTM-38.17% Profit Margin-29.80% Recom2.60 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q70.87% Payout- Rel Volume0.32 Prev Close11.95
Sales Surprise-9.40% EPS Surprise-40.72% Sales Q/Q-2.11% EarningsAug 08 BMO Avg Volume8.66M Price11.63
SMA20-4.26% SMA50-10.50% SMA20038.14% Trades Volume2,759,304 Change-2.68%
Date Action Analyst Rating Change Price Target Change
Jul-30-24Downgrade JP Morgan Neutral → Underweight $8
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
Sep-05-24 11:44AM
10:00AM
Sep-04-24 09:25AM
09:15AM
Sep-03-24 09:35AM
10:53AM Loading…
Sep-02-24 10:53AM
07:34AM
Aug-30-24 04:47PM
04:19PM
04:06PM
Aug-29-24 12:00PM
Aug-28-24 09:00AM
Aug-24-24 11:20AM
Aug-22-24 02:33PM
01:41PM
12:08PM Loading…
Aug-19-24 12:08PM
Aug-14-24 09:00AM
Aug-09-24 11:09AM
Aug-08-24 12:08PM
09:15AM
08:11AM
08:02AM
07:47AM
07:20AM
Aug-05-24 10:19AM
Aug-03-24 05:29AM
Aug-01-24 05:45PM
09:25AM
08:15AM
Jul-31-24 11:52AM
04:55PM Loading…
Jul-30-24 04:55PM
04:05PM
Jul-29-24 09:00AM
Jul-25-24 01:28PM
Jul-23-24 09:41AM
Jul-16-24 09:00AM
Jul-15-24 09:30AM
Jul-08-24 05:45PM
Jul-03-24 06:55AM
Jul-02-24 08:30AM
Jul-01-24 11:00PM
07:38AM
Jun-29-24 08:55AM
08:35AM
Jun-28-24 05:45PM
06:30AM
Jun-27-24 02:21PM
Jun-25-24 07:00PM
04:37PM
11:42AM
06:33AM
Jun-24-24 09:18AM
09:00AM
Jun-22-24 03:42AM
Jun-20-24 05:45PM
Jun-18-24 10:29AM
05:52AM
Jun-17-24 12:02PM
04:32AM
Jun-14-24 02:05PM
04:55AM
Jun-13-24 11:02AM
Jun-11-24 06:00AM
05:10AM
Jun-10-24 09:00AM
Jun-07-24 07:30AM
Jun-06-24 04:37PM
04:15PM
11:38AM
10:48AM
09:58AM
09:28AM
Jun-05-24 04:51PM
Jun-04-24 06:00AM
Jun-03-24 05:43PM
03:41PM
01:23PM
Jun-01-24 06:01AM
May-31-24 06:57AM
May-30-24 09:25AM
May-28-24 09:00AM
May-24-24 05:55PM
08:15AM
May-23-24 12:45PM
06:45AM
May-22-24 10:48AM
09:45AM
05:50AM
May-21-24 09:01AM
06:27AM
May-20-24 03:29PM
02:31PM
01:53PM
01:37PM
07:40AM
07:39AM
06:35AM
May-19-24 08:49AM
May-18-24 07:35AM
May-17-24 06:45AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trizzino JohnEVP, CCO and CBOAug 19 '24Option Exercise0.00655028,627Aug 21 04:47 PM
Kelly James PatrickEVP, CFO and TreasurerAug 16 '24Option Exercise12.962,36730,67615,652Aug 20 05:06 PM
YOUNG JAMES FDirectorJun 21 '24Sale14.097,500105,67561,760Jun 25 04:12 PM
YOUNG JAMES FDirectorJun 18 '24Sale13.727,500102,88169,260Jun 21 04:21 PM
Dubovsky FilipPresident, R&DJun 17 '24Option Exercise6.1813,90485,91180,517Jun 20 05:08 PM
Dubovsky FilipPresident, R&DJun 17 '24Sale14.4713,904201,16466,613Jun 20 05:08 PM
MCGLYNN MARGARET GDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:14 PM
Alton Gregg HDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:11 PM
DOUGLAS RICHARDDirectorJun 12 '24Option Exercise0.006,670043,920Jun 14 04:10 PM
King Rachel K.DirectorJun 12 '24Option Exercise0.006,670018,920Jun 14 04:07 PM
MOTT DAVID MDirectorJun 12 '24Option Exercise0.006,670050,470Jun 14 04:06 PM
Rodgers Richard JDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:05 PM
YOUNG JAMES FDirectorJun 12 '24Option Exercise0.006,670076,760Jun 14 04:01 PM
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16 '23Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM